Our multi-disciplinary teams are experts in delivering cGMP compliant secondary manufacturing facilities, helping clients convert active drug substances into finished products for market. We’re known for our attention to detail, ensuring the controlled conditions essential for the manufacture of a range of drugs from oral solid dose tablets and capsules to inhalations and injectables. We specialise in understanding the controlled environments and regulations needed for aseptic and sterile operations.
With an approach focused on efficiency, safety, compliance, sustainability, and constructability, we’re able to optimise our clients' processes, helping them to scale-up production from clinical development through pilot plants and into commercial manufacturing facilities. Our extensive experience in aseptic fill finish and finished goods, including use of robotics and fully automated systems means we’re well placed to meet the growing demand for flexibility.
In an environment where technology develops quickly, compliance measures are always evolving, products are needed in ever shorter timescales and costs are under continuous review, the challenges to develop new, life improving treatments and drugs are increasingly difficult. Our understanding of the latest technology and equipment combined with all the regulatory know-how means we can support our clients throughout the project lifecycle, providing medicines and treatments for patients across the globe.
